MSS
MDT icon

Mitchell Sinkler & Starr’s Medtronic MDT Stock Holding History

Mitchell Sinkler & Starr’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$512K Buy
6,551
+92
+1% +$7.42K 0.21% 100
2026
Q1 		$560K Hold
6,459
– – 0.26% 85
2025
Q4 		$620K Sell
6,459
-86
-1% -$8.35K 0.28% 77
2025
Q3 		$623K Sell
6,545
-5
-0.1% -$460 0.28% 79
2025
Q2 		$571K Sell
6,550
-158
-2% -$13.4K 0.27% 83
2025
Q1 		$603K Sell
6,708
-2,757
-29% -$247K 0.17% 92
2024
Q4 		$756K Sell
9,465
-91
-1% -$7.88K 0.2% 80
2024
Q3 		$860K Buy
9,556
+666
+7% +$56K 0.22% 79
2024
Q2 		$722K Buy
8,890
+331
+4% +$27.1K 0.19% 84
2024
Q1 		$746K Sell
8,559
-2,792
-25% -$238K 0.19% 87
2023
Q4 		$935K Buy
+11,351
New +$865K 0.17% 100
2023
Q3 		– Sell
-10,021
Closed -$883K – 119
2023
Q2 		$883K Sell
10,021
-478
-5% -$41.2K 0.25% 73
2023
Q1 		$846K Buy
10,499
+4,298
+69% +$350K 0.25% 76
2022
Q4 		$482K Buy
6,201
+398
+7% +$32.3K 0.16% 93
2022
Q3 		$469K Buy
5,803
+1,070
+23% +$96.2K 0.18% 78
2022
Q2 		$425K Buy
4,733
+85
+2% +$8.61K 0.16% 81
2022
Q1 		$516K Sell
4,648
-40
-0.9% -$4.23K 0.16% 80
2021
Q4 		$485K Hold
4,688
– – 0.14% 85
2021
Q3 		$588K Sell
4,688
-80
-2% -$10.4K 0.53% 59
2021
Q2 		$592K Sell
4,768
-23
-0.5% -$2.89K 0.54% 59
2021
Q1 		$566K Sell
4,791
-648
-12% -$75.9K 0.55% 59
2020
Q4 		$637K Buy
5,439
+140
+3% +$15.4K 0.61% 57
2020
Q3 		$551K Sell
5,299
-320
-6% -$32.1K 0.56% 58
2020
Q2 		$515K Hold
5,619
– – 0.58% 53
2020
Q1 		$507K Buy
5,619
+315
+6% +$33.5K 0.66% 51
2019
Q4 		$602K Buy
5,304
+1,300
+32% +$143K 0.64% 54
2019
Q3 		$435K Buy
4,004
+478
+14% +$49.9K 0.56% 56
2019
Q2 		$343K Sell
3,526
-540
-13% -$49.3K 0.39% 76
2019
Q1 		$370K Sell
4,066
-258
-6% -$23.1K 0.43% 74
2018
Q4 		$393K Sell
4,324
-215
-5% -$20.1K 0.49% 66
2018
Q3 		$447K Sell
4,539
-669
-13% -$61.9K 0.47% 69
2018
Q2 		$446K Sell
5,208
-400
-7% -$33.4K 0.49% 71
2018
Q1 		$450K Buy
5,608
+1,046
+23% +$86.3K 0.51% 62
2017
Q4 		$368K Hold
4,562
– – 0.54% 60
2017
Q3 		$355K Hold
4,562
– – 0.56% 61
2017
Q2 		$405K Hold
4,562
– – 0.66% 54
2017
Q1 		$368K Hold
4,562
– – 0.6% 58
2016
Q4 		$325K Buy
4,562
+120
+3% +$9.43K 0.46% 64
2016
Q3 		$384K Sell
4,442
-1,413
-24% -$123K 0.6% 55
2016
Q2 		$508K Sell
5,855
-357
-6% -$28.9K 0.69% 45
2016
Q1 		$466K Sell
6,212
-238
-4% -$17.9K 0.64% 54
2015
Q4 		$496K Sell
6,450
-1
-0% -$75 0.68% 49
2015
Q3 		$432K Buy
6,451
+1,986
+44% +$146K 0.56% 61
2015
Q2 		$331K Sell
4,465
-146
-3% -$11.2K 0.39% 69
2015
Q1 		$360K Buy
+4,611
New +$349K 0.41% 64

Other funds holding MDT

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Mitchell Sinkler & Starr's MDT Position: Q2 2026 in Review

Mitchell Sinkler & Starr increased its Medtronic (MDT) stake by 1.4% in Q2 2026, buying an estimated $7.42K and bringing the position to 6,551 shares worth $512K. The position accounts for 0.21% of the portfolio, ranked #100.

Mitchell Sinkler & Starr first reported a position in MDT in Q1 2015 and has held it in 45 quarters since. The position peaked at $935K in Q4 2023. 664 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Mitchell Sinkler & Starr held 6,551 shares of Medtronic worth $512K as of Q2 2026.
  • Mitchell Sinkler & Starr bought 92 Medtronic shares in Q2 2026, an estimated $7.42K.
  • Medtronic made up 0.21% of Mitchell Sinkler & Starr's portfolio in Q2 2026, its #100 holding.
  • Mitchell Sinkler & Starr first reported a position in Medtronic in Q1 2015 and has held it in 45 quarters since.
  • Mitchell Sinkler & Starr's Medtronic position peaked at $935K in Q4 2023.
  • 664 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.